Redhill Biopharma Ltd (NASDAQ:RDHL)

14.17
Delayed Data
As of Feb 27
 +0.12 / +0.85%
Today’s Change
6.89
Today|||52-Week Range
21.00
+6.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues22.9K16.0K12.0K6.9M
 
 
 
 
 
Cost of Goods Sold0.00----1.0M
 
 
Depreciation And Amortization14.9K24.0K24.1K26.6K
 
 
 
 
 
 
Operating ExpensesGross Income8.0K----5.9M
 
 
 
General Expenses7.9M9.0M10.8M16.5M
 
 
 
 
 
Research And Development5.4M6.5M8.1M12.5M
 
 
 
 
 
Total Operating Expenses7.9M9.1M10.8M17.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.8M-9.0M-10.8M-10.6M
 
 
 
 
 
Extraordinary Credit0.0057.0K54.1K--
 
 
 
Extraordinary Charge-7.9M0.000.00--
 
 
Other Expenses306.8K-1.3M90.2K-279.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.4M-10.3M-10.7M-10.6M
 
 
 
 
 
Net Income-15.4M-10.3M-10.7M-10.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.8M5.3M6.2M8.7M
 
 
 
 
 
Shares To Calculate EPS Diluted4.8M5.3M6.2M8.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.19-$2.00-$1.70-$1.18
 
 
 
 
 
EPS Diluted-$3.19-$2.00-$1.70-$1.28
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account